Package 62135-917-38

Brand: levocetirizine dihydrochloride

Generic: levocetirizine dihydrochloride
NDC Package

Package Facts

Identity

Package NDC 62135-917-38
Digits Only 6213591738
Product NDC 62135-917
Product ID 62135-917_0782ae1c-d903-d465-e063-6294a90a6676
Description

148 mL in 1 BOTTLE (62135-917-38)

Marketing

Marketing Status
Marketed Since 2022-08-30
Brand levocetirizine dihydrochloride
Generic levocetirizine dihydrochloride
Sample Package No

Linked Drug Pages (1)

Levocetirizine Dihydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0782ae1c-d903-d465-e063-6294a90a6676", "openfda": {"upc": ["0362135917388"], "unii": ["SOD6A38AGA"], "rxcui": ["855168"], "spl_set_id": ["b56652ad-2cf8-4ed0-bb66-0e832772c792"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "148 mL in 1 BOTTLE (62135-917-38)", "package_ndc": "62135-917-38", "marketing_start_date": "20220830"}], "brand_name": "Levocetirizine Dihydrochloride", "product_id": "62135-917_0782ae1c-d903-d465-e063-6294a90a6676", "dosage_form": "SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "62135-917", "generic_name": "Levocetirizine Dihydrochloride", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levocetirizine Dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": ".5 mg/mL"}], "application_number": "ANDA204599", "marketing_category": "ANDA", "marketing_start_date": "20170515", "listing_expiration_date": "20261231"}